|
Market Closed -
Euronext Paris
10:25:00 30/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.7260 EUR | +0.41% |
|
+6.76% | -24.38% |
| 05/10 | Transgene to present preclinical data on PoxSTG-EEV |  |
| 25/09 | Transgene provides update on its operations | |
Company Valuation: Transgene
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 247.8 | 164.8 | 137.8 | 89.75 | 262.9 | 198.8 | - | - |
| Change | - | -33.52% | -16.38% | -34.86% | 192.89% | -24.36% | - | - |
| Enterprise Value (EV) 1 | 214.9 | 151.4 | 139.4 | 83.48 | 153.1 | 129.6 | 191.1 | 217.4 |
| Change | - | -29.53% | -7.95% | -40.12% | 83.37% | -15.31% | 47.44% | 13.76% |
| P/E | -12.1x | -5.02x | -6.23x | -2.34x | -3.69x | -5.19x | -3.3x | -8.07x |
| PBR | 3.69x | 4.38x | 8.82x | 5.92x | 1.14x | 2.42x | 9.08x | -72.6x |
| PEG | - | -0.1x | 0.2x | -0.1x | 0.4x | 0.1x | -0.1x | 0.1x |
| Capitalization / Revenue | 14.2x | 15.9x | 17.4x | 14.1x | 36.5x | 27.6x | 27.6x | 3.48x |
| EV / Revenue | 12.3x | 14.6x | 17.6x | 13.1x | 21.2x | 18x | 26.5x | 3.8x |
| EV / EBITDA | -10.2x | -5.37x | -4.9x | -2.43x | -4.54x | -2.97x | -2.73x | -9.21x |
| EV / EBIT | -9.14x | -5.06x | -4.64x | -2.34x | -4.37x | -2.93x | -2.7x | -7.42x |
| EV / FCF | -6.59x | -6.94x | -1,408x | -3.12x | -1.07x | -3.27x | -3.16x | -8.66x |
| FCF Yield | -15.2% | -14.4% | -0.07% | -32% | -93.4% | -30.6% | -31.6% | -11.5% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.21 | -0.33 | -0.22 | -0.29 | -0.26 | -0.14 | -0.22 | -0.09 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 17.41 | 10.34 | 7.9 | 6.353 | 7.21 | 7.2 | 7.2 | 57.2 |
| EBITDA 1 | -21 | -28.22 | -28.48 | -34.38 | -33.73 | -43.6 | -70.1 | -23.6 |
| EBIT 1 | -23.52 | -29.9 | -30.05 | -35.66 | -35.06 | -44.3 | -70.8 | -29.3 |
| Net income 1 | -19.54 | -32.8 | -22.33 | -33.97 | -37.52 | -38.2 | -61.6 | -25.3 |
| Net Debt 1 | -32.93 | -13.31 | 1.629 | -6.274 | -109.8 | -69.2 | -7.7 | 18.6 |
| Reference price 2 | 2.5400 | 1.6580 | 1.3700 | 0.6800 | 0.9600 | 0.7260 | 0.7260 | 0.7260 |
| Nbr of stocks (in thousands) | 97,576 | 99,370 | 1,00,566 | 1,31,990 | 2,73,827 | 2,73,882 | - | - |
| Announcement Date | 16/03/22 | 16/03/23 | 27/03/24 | 27/03/25 | 24/03/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.19x | 18.01x | -2.97x | - | 22Cr | |
| 16.87x | 6.34x | 12.15x | 1.77% | 6.38TCr | |
| 30.14x | 8.25x | 27.02x | 0.04% | 5.64TCr | |
| 37.48x | 6.65x | 19.85x | 0.86% | 5.46TCr | |
| 34.93x | 3.32x | 14.34x | -.--% | 4.41TCr | |
| 48.85x | 5.63x | 30.81x | -.--% | 4.21TCr | |
| -19.86x | 192.36x | -21.16x | -.--% | 4.1TCr | |
| 47.33x | 8.41x | 28.18x | -.--% | 3.49TCr | |
| 32x | 8.13x | 21.15x | 0.41% | 3.28TCr | |
| -64.56x | 13.05x | -73.23x | -.--% | 2.47TCr | |
| Average | 15.80x | 27.02x | 5.61x | 0.34% | 3.95TCr | |
| Weighted average by Cap. | 22.07x | 26.33x | 10.93x | 0.45% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- TNG Stock
- Valuation Transgene
Select your edition
All financial news and data tailored to specific country editions
